Tech & Pharma
Companies in Japan and India have started utilizing floating power farms to circumvent the lack of space on land.
ASLAN has begun treating its first gastric cancer patients in Taiwan, where 4,000 people are affected by the disease annually.
KAIST partners gene editing company ToolGen to develop methods of increasing biofuel yield from microalgae.
Biocon organized a week of free oral cancer screening activities across 23 Indian cities from September 1-7, 2014.
Luye Pharma strengthens its position in China’s cardiovascular drug market with the US$600 million acquisition of Beijing Jialin Pharmaceutical.
Singapore’s A*STAR and LTA have set up a partnership to propel the development of automated vehicle systems within the country.
The Combined Heat and Power plant jointly developed by A*STAR and Hitachi achieves high efficiency with low operation costs.
Eisai grants Zeria the right to manufacture E3710, a proton pump inhibitor than can be used to treat gastric acid-related diseases.
Green Cross receives regulatory approval for its once-per-cycle dose neutropenia drug, Neulapeg®.
The CFDA approval of Mecobalamin marks Amerigen’s entry into the Chinese generics market.